|
|
|
|
| Joint Commission Cracks Down on Bullying |
|
The abusive, manipulative and just plain nasty treatment that many healthcare professionals get from their peers on a daily basis has got to stop, says the Joint Commission in a new Sentinel Event Alert, the first to deal with the hot-button issue of lateral violence in the workplace.
"The inherent stresses of dealing with high stakes, high-emotion situations can contribute to occasional intimidating or disruptive behavior, particularly in the presence of factors such as fatigue," warns the alert. "Individual care providers who exhibit characteristics such as self-centeredness, immaturity or defensiveness can be more prone to unprofessional behavior."
This disruptive behavior, which can range from verbal and physical aggression to passive hostilities like refusing to cooperate with colleagues, can heighten the risk of medical errors and poor outcomes, reduce patient satisfaction, increase costs and drive quality professionals out of the business, says the commission.
"It is important for organizations to take a stand by clearly identifying such behaviors and refusing to tolerate them," says Joint Commission President Mark R. Chassin, MD, MPP, MPH, in a statement.
To that end, the commission has established 11 steps for accredited hospitals, surgery centers and other healthcare organizations to take by Jan. 1, 2009, including the following:
educate and train all team members, including clinicians and staff, on appropriate workplace behavior;
hold team members accountable for adhering to and enforcing the facility's code of conduct;
develop and implement procedures to address lateral violence, including a zero-tolerance policy, a reporting and surveillance system and non-retaliation clauses to protect those who witness and report disruptive behaviors; and
address problematic behaviors with non-confrontational intervention strategies focused on rehabilitating the abuser and preserving patient safety.
Irene Tskitas |
|
 |
^ Back to Top |
|
|
|
|
| Study: Specialty Hospital Physician-owners More Likely to Refer Patients for Surgery |
|
The physician-owners of specialty hospitals are more likely to refer patients to the facility for surgery, imaging and other procedures than non-owners are, according to a study published in the July issue of the journal Medical Care
To determine this effect, Jean Mitchell, PhD, a professor of public policy at Georgetown University, analyzed the practice patterns for physicians who did and did not become part-owners at one of two specialty hospitals in Tulsa, Okla., one a spine hospital, the other an orthopedic hospital.
She found that the part-owners were far more likely to refer their patients for certain procedures. Complex spinal fusion surgery schedulings, for instance, jumped from 0.1 percent before a physician's ownership to 6.51 percent after, while the figure remained at less than one percent for physicians with no ownership.
During the same time, physician-owners referred fewer patients for less expensive spinal surgeries, even as such referrals from non-owners increased. Physician-owners were also more likely to refer patients for ancillary services such as physical therapy and MRI scans to the specialty hospitals.
Dr. Mitchell attributes these referral patterns to their financial incentive. "Physician incomes in real terms have declined since the mid-1990's, in part due to Medicare and private insurance cutting the rates for surgeries, diagnostic procedures and office-based procedures," she says. "If you see your income going down, it's natural to try to bring it back up, and expanding the scope of practice by becoming owners of a specialty hospital is one way for physicians to do that."
She says her findings suggest that health care expenditures will be substantially greater for patients treated at these facilities compared to patients who get care from healthcare providers who do not use self-referrals.
Nathan Hall |
|
 |
^ Back to Top |
|
|
|
|
| Efficacy of Cadaver Ligaments Questioned |
|
Nearly one-fourth of cadaver ligaments implanted in young athletes during ACL reconstructions fail, a discovery that may promote the use of grafts taken from the patients' own tissue. The findings were announced last week at the American Orthopaedic Society for Sports Medicine's annual meeting in Orlando, Fla.
Researchers spent two years monitoring 64 patients who underwent ACL reconstruction with a cadaver ligament. They found that 15 patients (23.4 percent) required a second knee reconstruction due to injury, graft failure or low scores on post-op outcome measures.
The failure of cadaver ligaments occurred in patients 40 years and younger who were active in sports that place stress on the ACL ligament, including tennis, basketball, soccer and downhill skiing, says the study's co-author, Kurre Luber, MD, an orthopedic surgery fellow at Mississippi Sports Medicine and Orthopaedic Center in Jackson, Miss.
"Certainly, it would be naive to think that only the graft selection led to these failures. We also need to look at surgical technique," such as single- versus double-bundle procedures, says Dr. Luber. "Better outcome measures also need to be developed. However, this study definitely raises questions about the validity of using cadaver tissue in this patient subgroup."
Patients over 40 years old who received cadaver implants had a 2.4 percent failure rate, much lower than the younger cohort. "While there are obvious benefits of using the cadaver ligament, like avoiding a second surgical site on the patient, a quicker return to work and less postoperative pain, for a young patient who is very active, it may not be the right choice," says the study's corresponding author, Gene Barrett, MD, of the Mississippi Sports Medicine and Orthopaedic Center.
Daniel Cook |
|
 |
^ Back to Top |
|
|
|
|
| News & Notes |
|
CHG product recall text. Calling it a precautionary measure, Sage Products has voluntarily recalled limited lots of its 2% Chlorhexidine Gluconate (CHG) Cloth Patient Preoperative Skin Preparation. Testing of the product from an outside supplier revealed the presence of Burkholderia cepacia, a known cause of infections among hospitalized patients which poses little medical risk to healthy people, says the company. The affected product was shipped between April 28 and June 19. The effects of B. cepacia range from an absence of symptoms to serious respiratory infections, especially in patients with cystic fibrosis. Sage has received no reports of patient injury.
Better-integrating implants Researchers at the Georgia Institute of Technology are experimenting with a polymer coating for titanium joint implants that boosts tissue healing, bone growth and structural attachment, according to a study published in the July issue of the journal Biomaterials. The effects of the coating, which incorporates an engineered protein inspired by one that attracts healing cells, may increase the lifespan of hip and knee implants and perhaps forestall the need for patients to replace previously replaced joints.
New drug indication Aloxi (palonosetron hydrochloride) injection 0.075mg is now available as a preventative measure against post-operative nausea and vomiting for up to 24 hours following surgery, according to pharmaceutical firm Eisai, which acquired MGI Pharma, Inc., the drug's creator, in January 2008. The FDA approved the drug - introduced as an anti-emetic for chemotherapy patients in 2003 - for use against PONV in February 2008. |
|
|
^ Back to Top |
|
|
|
|
|
|